15
Participants
Start Date
March 4, 2019
Primary Completion Date
August 5, 2019
Study Completion Date
August 5, 2019
Omeprazole
Omeprazole (20 mg) will be administered orally once daily for 5 days in one of the two treatment periods.
Placebo oral tablet
Placebo will be administered orally once daily for 5 days in one of the two treatment periods.
Gliclazide
Gliclazide (40 mg) will be administered orally once, concomitantly with omeprazole or placebo on day 5.
General Hospital Prim. Dr. Abdulah Nakas, Sarajevo
General Hospital Prim. Dr. Abdulah Nakas
OTHER
University of Dundee
OTHER
Wellcome Trust
OTHER
University of Sarajevo
OTHER